myBIOS

myBIOS is a biotechnology company specializing in the recombinant production of natural biomaterials. The company leverages the unique physical and biochemical properties of protein-based biological molecules to create solutions for various industries. These biopolymers, characterized by repetitive amino acid sequences, exhibit special properties such as strength, elasticity, and functionality in diagnostics and vaccines. myBIOS serves clients in the pharmaceutical, healthcare, and research sectors, providing products and services including protein production, strain collection, antigens, and antibody tests. Operating in the biotech market, myBIOS employs a business model centered around the development and sale of high-value biopolymers and related services. Revenue is generated through the provision of customized protein production services and the sale of proprietary biopolymer products.

Keywords: recombinant proteins, biopolymers, diagnostics, vaccines, smart materials, protein production, strain collection, antigens, antibody tests, biotech solutions.